High materiality7/10
Prime Medicine (PRME) Reiterated at Market Outperform by Goldman Sachs
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs reiterates Market Outperform with a $6 target; price $3.23.
- Goldman Sachs reiterates Market Outperform with a $6 target; current price $3.23.
Key facts
- 01
Target: $6
- 02
Posted price: $3.23
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.